MetLife Investment Management’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-993	Closed	-$119K	–	2317
2020 Q3	$119K	Buy	993 +219	+28%	+$26.2K	﹤0.01%	2137
2020 Q2	$96.4K	Buy	+774	New	+$96.4K	﹤0.01%	2266